The order relates to the supply of oncology drugs, among others: Nintedanib, Atezolizumab, Pembrolizumab and growth factors. The detailed assortment, doses and estimated quantities are given in the assortment sheet set out in Annex 6 to SWZ.
Supplies of NintedanibThe order applies to the supply of the drug Nintedanib. The detailed assortment, doses and estimated quantities are given in the assortment sheet set out in Annex 6 to SWZ
Supplies of AtezolizumabThe order applies to supplies of Atezolizumab. The detailed assortment, doses and estimated quantities are given in the assortment sheet set out in Annex 6 to SWZ
Supplies of PembrolizumabThe order applies to the supply of Pembrolizumab concentrate for solution preparation. The detailed assortment, doses and estimated quantities are given in the assortment sheet set out in Annex 6 to SWZ
Supplies of growth factorsThe order applies to the supply of Filigrastim and Pegfiligrastim. The detailed assortment, doses and estimated quantities are given in the assortment sheet set out in Annex 6 to SWZ